Cargando…

Development of zoledronic acid functionalized hydroxyapatite loaded polymeric nanoparticles for the treatment of osteoporosis

The present study formulated a hydroxyapatite (HA)-coated lipid nanoparticle loaded with zoledronic acid to treat patients with osteoporosis (OP). HA-coated zoledronic acid loaded lipid bilayer nanoparticles (HZL NPs) were prepared using methods of extrusion and precipitation. Nanosized particles we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Yunlu, Gao, Tiantian, Fu, Shiping, Sun, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090242/ https://www.ncbi.nlm.nih.gov/pubmed/30116324 http://dx.doi.org/10.3892/etm.2018.6263

Ejemplares similares

Therapeutic Effects of Zoledronic Acid-Loaded Hyaluronic Acid/Polyethylene Glycol/Nano-Hydroxyapatite Nanoparticles on Osteosarcoma
por: Xu, Yan, et al.
Publicado: (2022)

Zoledronic Acid-Loaded Hybrid Hyaluronic Acid/Polyethylene Glycol/Nano-Hydroxyapatite Nanoparticle: Novel Fabrication and Safety Verification
por: Xu, Yan, et al.
Publicado: (2021)

Role of zoledronic acid in the prevention and treatment of osteoporosis
por: Räkel, Agnès, et al.
Publicado: (2011)

Zoledronic acid infusion for prevention and treatment of osteoporosis
por: Sunyecz, John A
Publicado: (2010)

Development of clinical utility of zoledronic acid and patient considerations in the treatment of osteoporosis
por: Ringe, Johann D
Publicado: (2010)

Management of osteoporosis in the aging male: Focus on zoledronic acid
por: Piper, Paul K, et al.
Publicado: (2009)

Six monthly intravenous zoledronic acid in childhood osteoporosis
por: Munns, CF, et al.
Publicado: (2013)

Clinical effect of Zoledronic Acid in the treatment of Senile Osteoporosis
por: Kong, Li, et al.
Publicado: (2020)

How zoledronic acid improves osteoporosis by acting on osteoclasts
por: Wang, Biao, et al.
Publicado: (2022)

Acute effect of zoledronic acid infusion on atrial fibrillation development in patients with osteoporosis
por: İlgezdi, Zeynep Demet, et al.
Publicado: (2015)

Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients
por: Xie, Jun, et al.
Publicado: (2019)

Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management
por: Dalle Carbonare, Luca, et al.
Publicado: (2010)

Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis
por: Serefoglu, Ege Can, et al.
Publicado: (2010)

Study on the role of zoledronic acid in treatment of postmenopausal osteoporosis women
por: Chao, Ma, et al.
Publicado: (2013)

Hepatotoxicity induced by zoledronic acid in an aged woman with primary osteoporosis
por: Lu, Yanhui, et al.
Publicado: (2013)

Predicting the individualized risk of nonadherence to zoledronic acid among osteoporosis patients receiving the first infusion of zoledronic acid: development and validation of new predictive nomograms
por: Li, Chong, et al.
Publicado: (2022)

Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture
por: Chapurlat, Roland D
Publicado: (2009)

Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect
por: Lewiecki, E Michael
Publicado: (2010)

Safety & Efficacy of Cyclic Zoledronic Acid Therapy on Pediatric Secondary Osteoporosis
por: Al-Agha, Abdulmoein E., et al.
Publicado: (2016)

Single Dose Therapy of Zoledronic Acid for the Treatment of Transient Osteoporosis of Hip
por: Agarwala, Sanjay, et al.
Publicado: (2019)

Adherence to and persistence with zoledronic acid treatment for osteoporosis—reasons for early discontinuation
por: Spångeus, Anna, et al.
Publicado: (2020)

Synergistic effect of graphene oxide and zoledronic acid for osteoporosis and cancer treatment
por: Boran, Gökçen, et al.
Publicado: (2020)

Safety and Efficacy of Zoledronic Acid Treatment with and without Acetaminophen and Eldecalcitol for Osteoporosis
por: Mochizuki, Takeshi, et al.
Publicado: (2021)

Retrospective Study of the Effects of Zoledronic Acid on Muscle Mass in Osteoporosis Patients
por: Huang, Chun-Feng, et al.
Publicado: (2021)

Zoledronate loaded polylactic acid/polycaprolactone/hydroxyapatite scaffold accelerates regeneration and led to enhance structural performance and functional ability of the radial bone defect in rat
por: Oryan, A., et al.
Publicado: (2023)

Investigation of the treatment potential of Raloxifene-loaded polymeric nanoparticles in osteoporosis: In-vitro and in-vivo analyses
por: Guo, Zhonghua, et al.
Publicado: (2023)

Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass
por: Hamdy, Ronald C
Publicado: (2010)

Treatment of postmenopausal osteoporosis, patient perspectives – focus on once yearly zoledronic acid
por: Carmona, Raj, et al.
Publicado: (2009)

Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
por: Miller, P. D., et al.
Publicado: (2016)

Symptomatic Hypocalcemia Associated with Zoledronic Acid Treatment for Osteoporosis: A Case Report
por: Al Elq, Abdulmohsen H.
Publicado: (2013)

Denosumab versus zoledronic acid for patients with beta-thalassemia major-induced osteoporosis
por: Yassin, Mohamed A., et al.
Publicado: (2020)

Zoledronic acid-induced hepatotoxicity relieved after subsequent infusions in a Chinese woman with glucocorticoid-induced osteoporosis
por: Jiang, Yan, et al.
Publicado: (2015)

Systemic and local zoledronic acid treatment with hydroxyapatite bone graft: A histological and histomorphometric experimental study
por: Günes, Nedim, et al.
Publicado: (2016)

Incorporation of Chloramphenicol Loaded Hydroxyapatite Nanoparticles into Polylactide
por: Rivas, Manuel, et al.
Publicado: (2019)

Effect of Zoledronic Acid on Acro-Osteolysis and Osteoporosis in a Patient with Hajdu-Cheney Syndrome
por: Hwang, Sena, et al.
Publicado: (2011)

Assessment of the Impact of Zoledronic Acid on Ovariectomized Osteoporosis Model Using Micro-CT Scanning
por: Shuai, Bo, et al.
Publicado: (2015)

Cost-effectiveness of single-dose zoledronic acid for nursing home residents with osteoporosis in the USA
por: Ito, Kouta
Publicado: (2018)

Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan
por: Moriwaki, K., et al.
Publicado: (2017)

Short-term efficacy and safety of zoledronate acid or denosumab in Japanese patients with postmenopausal osteoporosis
por: Nakamura, Yumejiro, et al.
Publicado: (2021)

IDUA Gene Variants and Response to Zoledronic Acid Treatment in Chinese Women with Postmenopausal Osteoporosis
por: Lin, Haiqing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3d79h68ajei9eh1astb5fjbj89